Earnings History Data for Unicycive Therapeutics, Inc. (UNCY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Unicycive Therapeutics, Inc.

Unicycive Therapeutics Inc. is a clinical stage biotechnology company. It involved in developing therapies for patients with kidney disease. The company's lead drug consist Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. Unicycive Therapeutics Inc. is based in LOS ALTOS, Calif.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-08-2024 PM UNCY Unicycive Therapeutics 13.00 -0.15 -0.23 0.00 Unicycive Therapeutics GAAP EPS of -$0.29
[8/14/2024 12:17 PM]
0.3140 0.08 
(33.05%)
0.26 0.03 
(11.02%)
0.20 - 1.82 13,655,996 3,740,000 918,870
13-05-2024 AH UNCY Unicycive Therapeutics 41.00 -0.27 -0.18 0.00 Unicycive Therapeutics reports Q1 GAAP EPS of -$0.61
[5/14/2024 12:36 PM]
1.08 -0.01 
(-0.46%)
1.09 0.0 
(0.00%)
0.47 - 1.82 139,333 250,000 2,310
28-03-2024 AH UNCY Unicycive Therapeutics 50.00 -0.16 -0.18 0.00 Unicycive Therapeutics GAAP EPS of -$1.28, revenue of $0.7M
[3/28/2024 5:03 PM]
1.38 -0.08 
(-5.48%)
1.38 0.0 
(0.00%)
0.47 - 2.29 167,704 400,000 4,075
14-08-2023 AH UNCY Unicycive Therapeutics 14.00 -0.29 -0.39 0.00 Unicycive Therapeutics GAAP EPS of $0.29 beats by $0.57
[8/15/2023 10:30 AM]
0.7966 -0.02 
(-2.91%)
0.86 0.04 
(4.81%)
0.40 - 2.87 110,786 80,000 1,722
16-05-2023 PM UNCY Unicycive Therapeutics 21.00 -0.29 -0.36 0.00 Unicycive Therapeutics GAAP EPS of -$0.24
[5/16/2023 9:20 AM]
1.38 -0.05 
(-3.50%)
0.0 0.0 
(0.00%)
0.40 - 2.87 63,207 350,000 0
31-03-2023 PM UNCY Unicycive Therapeutics, Inc. 7.77 -0.35 -0.38 -0.17 Unicycive Therapeutics GAAP EPS of -$1.20 misses by $0.11
[3/31/2023 7:50 AM]
2.07 0.19 
(10.11%)
1.88 0.0 
(0.00%)
0.40 - 2.87 932,788 940,000 2,577
14-11-2022 PM UNCY Unicycive Therapeutics 10.00 -0.37 -0.35 0.00 Unicycive Therapeutics GAAP EPS of -$0.37 misses by $0.09, revenue of $0.95M
[11/14/2022 9:12 AM]
0.6750 -0.04 
(-5.59%)
0.70 -0.01 
(-2.10%)
0.51 - 3.10 21,197 30,000 600
15-08-2022 PM UNCY Unicycive Therapeutics, Inc. 12.02 -0.24 -0.27 -0.13 Unicycive Therapeutics GAAP EPS of -$0.24
[8/16/2022 3:12 AM]
0.70 0.0 
(-0.03%)
0.0 0.0 
(0.00%)
0.62 - 3.19 22,810 100,000 0
12-05-2022 PM UNCY Unicycive Therapeutics 11.00 -0.24 -0.20 0.00 Unicycive Therapeutics GAAP EPS of -$0.24 misses by $0.07
[5/12/2022 8:21 AM]
0.70 -0.02 
(-2.79%)
0.0 0.0 
(0.00%)
0.62 - 8.73 70,750 40,000 0
11-11-2021 PM UNCY Unicycive Therapeutics 41.00 -0.37 -0.11 0.00 Unicycive Therapeutics reports Q3 results
[11/11/2021 9:29 AM]
2.79 0.04 
(1.45%)
0.0 0.0 
(0.00%)
2.39 - 8.73 47,239 130,000 0